Question 1

BEAM vs MRK: which stock scores better overall?

Accepted Answer

Based on Q·Score, Merck & Company, Inc. (MRK) scores 6.7/10 versus Beam Therapeutics Inc. (BEAM) at 6/10. The Q·Score measures five dimensions: Quality, Value, Growth, Safety, and Momentum. For informational purposes only — not financial advice.

Question 2

Which has better revenue growth: BEAM or MRK?

Accepted Answer

Beam Therapeutics Inc. (BEAM) scores higher on Growth (7.2/10 vs 6.2/10). Beam Therapeutics Inc. reports revenue growth (279.5% YoY) while Merck & Company, Inc. reports (4.9% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.

Question 3

Is BEAM or MRK more attractively valued?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Value (7.2/10 vs 6.5/10). Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.

Question 4

What do analysts say about BEAM vs MRK?

Accepted Answer

There are 15 analysts covering BEAM with a consensus price target of $51.20, and 27 analysts covering MRK with a consensus target of $129.74. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.

Question 5

Which is more profitable: BEAM or MRK?

Accepted Answer

Merck & Company, Inc. (MRK) scores higher on Quality (6.2/10 vs 1.1/10). Net profit margin: BEAM at -57.2%, MRK at 13.6%. Quality scores reflect profit margins, return on equity, and free cash flow generation.

Question 6

Which has stronger financial health: BEAM or MRK?

Accepted Answer

Beam Therapeutics Inc. (BEAM) scores higher on Financial Health (8.7/10 vs 7/10). Market beta: BEAM at 2.19, MRK at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.

Question 7

What are the market caps of BEAM and MRK?

Accepted Answer

Beam Therapeutics Inc. (BEAM) has a market capitalisation of $3.2B, while Merck & Company, Inc. (MRK) has a market cap of $277.0B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.

Question 8

Do BEAM or MRK pay dividends?

Accepted Answer

BEAM does not currently pay a dividend, while MRK pays a dividend yield of 3.03%. Dividend yields fluctuate with share price and company payout decisions.

Beam Therapeutics Inc. vs Merck & Company, Inc. — Stock Comparison

Q·Score Breakdown

Analyst Consensus

Fundamentals